News
13d
KFF Health News on MSNCDC Staffing Upheaval Disrupts HIV Projects and Wastes Money, Researchers SayResearchers laid off in April were putting the finishing touches on in-depth HIV surveys that guide treatment and prevention.
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
6d
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
An HIV expert spoke to 11Alive about being among those who were on leave and are now being recalled at the CDC.
7don MSN
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results